Page last updated: 2024-09-04

2,9-dimethyl-beta-carbolinium and 9-hydroxyellipticine

2,9-dimethyl-beta-carbolinium has been researched along with 9-hydroxyellipticine in 1 studies

Compound Research Comparison

Studies
(2,9-dimethyl-beta-carbolinium)
Trials
(2,9-dimethyl-beta-carbolinium)
Recent Studies (post-2010)
(2,9-dimethyl-beta-carbolinium)
Studies
(9-hydroxyellipticine)
Trials
(9-hydroxyellipticine)
Recent Studies (post-2010) (9-hydroxyellipticine)
8007604

Protein Interaction Comparison

ProteinTaxonomy2,9-dimethyl-beta-carbolinium (IC50)9-hydroxyellipticine (IC50)
Mast/stem cell growth factor receptor KitHomo sapiens (human)0.205
Platelet-derived growth factor receptor alphaHomo sapiens (human)0.6
Fibroblast growth factor receptor 3Homo sapiens (human)0.4

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Denny, WA; Feigon, J; Kearns, DR; Leupin, W1

Other Studies

1 other study(ies) available for 2,9-dimethyl-beta-carbolinium and 9-hydroxyellipticine

ArticleYear
Interactions of antitumor drugs with natural DNA: 1H NMR study of binding mode and kinetics.
    Journal of medicinal chemistry, 1984, Volume: 27, Issue:4

    Topics: Antineoplastic Agents; Base Composition; Chemical Phenomena; Chemistry; DNA; Hydrogen Bonding; Intercalating Agents; Kinetics; Magnetic Resonance Spectroscopy; Structure-Activity Relationship

1984